Tidomet/Tidomet CR

Tidomet/Tidomet CR

carbidopa + levodopa

Manufacturer:

Torrent

Distributor:

Torrent
Concise Prescribing Info
Contents
Tidomet 100 mg/25 mg tab Levodopa 100 mg, carbidopa 25 mg. Tidomet 250 mg/25 mg tab Levodopa 250 mg, carbidopa 25 mg. Tidomet CR Levodopa 200 mg, carbidopa 50 mg
Indications/Uses
Symptoms of idiopathic Parkinson's disease (paralysis agitans), postencephalitic parkinsonism, which follows injury to nervous system by carbon monoxide & manganese intoxication.
Dosage/Direction for Use
Individualized dose. Tidomet 100 mg/25 mg tab Patient not previously treated w/ levodopa Initially 1 tab tid, increased gradually in increments of carbidopa 12.5 mg w/ levodopa 50 mg or carbidopa 25 mg w/ levodopa 100 mg daily or on alternate days as necessary. Maintenance: Carbidopa 75-200 mg w/ levodopa 750 mg to 2 g daily in divided doses. Max: Carbidopa 200 mg daily. Patient previously treated w/ levodopa 1/4 of dose previously being taken. Patient taking <1.5 g or >1.5 g levodopa Initially 1 tab tid or qid. Tidomet 250 mg/25 mg tab Initially 1 tab tid, may be increased by 1 tab/day or every other day as necessary, up to 8 tab/day. Tidomet CR tab Patient already receiving levodopa therapy & currently receiving levodopa alone Initially 1 tab bid adjusted according to response at intervals of not <3 days. Patient who are not already receiving initial dose Should not exceed 600 mg daily. Patient already receiving conventional prep Initially same dose to that of conventional prep but dosing intervals should be prolonged & normally between 4-12 hr. Alter dose & intervals according to response allowing at least 3 days between adjustments. Maintenance: Carbidopa 100 mg w/ levodopa 400 mg to carbidopa 400 mg w/ levodopa 1.6 g.
Administration
Should be taken on an empty stomach: If GI distress occurs, take w/ food. CR Tab: Swallow whole, do not chew/crush.
Contraindications
Hypersensitivity. Narrow-angle glaucoma, patients w/ suspicious undiagnosed skin lesions or history of melanoma. MAOIs.
Special Precautions
Discontinue use in patients receiving levodopa alone at least 8 hr before initiation of therapy. Patients w/ open-angle glaucoma, CV or pulmonary disease, endocrine disorders, psychiatric disturbances, osteomalacia, hepatic or renal disease, history of peptic ulceration, malignant melanoma. May impair ability to drive or operate machinery. Pregnancy & lactation.
Adverse Reactions
GI effects eg, nausea, vomiting & anorexia. GI bleeding. Orthostatic hypotension. Psychotic reactions. Dyskinesias.
Drug Interactions
Symptomatic postural hypotension may occur w/ antihypertensive drugs. HTN & dyskinesia w/ tricyclics. May reduce therapeutic effects w/ phenothiazines & butyrophenones. Levodopa: Reversed beneficial effects w/ phenytoin & papaverine. May affect absorption w/ gastric emptying drugs.
MIMS Class
Antiparkinsonian Drugs
ATC Classification
N04BA02 - levodopa and decarboxylase inhibitor ; Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
Presentation/Packing
Form
Tidomet CR 200 mg/50 mg CR tab
Packing/Price
30's (P2,229/pack)
Form
Tidomet 100 mg/25 mg tab
Packing/Price
100's (P3,350/pack)
Form
Tidomet 250 mg/25 mg tab
Packing/Price
100's (P5,300/pack)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in